Cargando…

Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension

Discovering novel uses for existing drugs, through drug repurposing, can reduce the time, costs, and risk of failure associated with new drug development. However, prioritizing drug repurposing candidates for downstream studies remains challenging. Here, we present a high-throughput approach to iden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Patrick, Feng, QiPing, Kerchberger, Vern Eric, Nelson, Scott D., Chen, Qingxia, Li, Bingshan, Edwards, Todd L., Cox, Nancy J., Phillips, Elizabeth J., Stein, C. Michael, Roden, Dan M., Denny, Joshua C., Wei, Wei-Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748496/ https://www.ncbi.nlm.nih.gov/pubmed/35013250 http://dx.doi.org/10.1038/s41467-021-27751-1

Ejemplares similares

Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer’s Disease in Real-World Clinical Datasets
por: Wei, Wei-Qi, et al.
Publicado: (2023)

PheMap: a multi-resource knowledge base for high-throughput phenotyping within electronic health records
por: Zheng, Neil S, et al.
Publicado: (2020)

High-throughput framework for genetic analyses of adverse drug reactions using electronic health records
por: Zheng, Neil S., et al.
Publicado: (2021)

Scanning the medical phenome to identify new diagnoses after recovery from COVID-19 in a US cohort
por: Kerchberger, Vern Eric, et al.
Publicado: (2022)

ConceptWAS: a high-throughput method for early identification of COVID-19 presenting symptoms
por: Zhao, Juan, et al.
Publicado: (2020)

ConceptWAS: A high-throughput method for early identification of COVID-19 presenting symptoms and characteristics from clinical notes
por: Zhao, Juan, et al.
Publicado: (2021)

Drug repurposing for Alzheimer’s disease from 2012–2022—a 10-year literature review
por: Grabowska, Monika E., et al.
Publicado: (2023)

Genome-wide association analyses of common infections in a large practice-based biobank
por: Jiang, Lan, et al.
Publicado: (2022)

Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health records
por: Feng, QiPing, et al.
Publicado: (2018)

The relationship between high density lipoprotein cholesterol and sepsis: A clinical and genetic approach
por: Liu, Ge, et al.
Publicado: (2023)

Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
por: Fang, Jiansong, et al.
Publicado: (2022)

Creation and Validation of an EMR-based Algorithm for Identifying Major Adverse Cardiac Events while on Statins
por: Wei, Wei-Qi, et al.
Publicado: (2014)

Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality
por: Xu, Hua, et al.
Publicado: (2015)

Combining Clinical and Candidate Gene Data into a Risk Score for Azathioprine-Associated Leukopenia in Routine Clinical Practice
por: Anandi, Prathima, et al.
Publicado: (2020)

Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia
por: Cybulsky, Marta, et al.
Publicado: (2016)

Alterations of Urinary Microbiota in Type 2 Diabetes Mellitus with Hypertension and/or Hyperlipidemia
por: Liu, Fengping, et al.
Publicado: (2017)

Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing
por: Wu, Yonghui, et al.
Publicado: (2019)

Using topic modeling via non-negative matrix factorization to identify relationships between genetic variants and disease phenotypes: A case study of Lipoprotein(a) (LPA)
por: Zhao, Juan, et al.
Publicado: (2019)

Malnutrition, hypertension, and hyperlipidemia as risk factors for recurrent cellulitis
por: Norimatsu, Yurie, et al.
Publicado: (2021)

Modified lingguizhugan decoction incorporated with dietary restriction and exercise ameliorates hyperglycemia, hyperlipidemia and hypertension in a rat model of the metabolic syndrome
por: Yao, Limei, et al.
Publicado: (2017)

Impact of Monthly Prescription Cap on Medication Persistence Among Patients with Hypertension, Hyperlipidemia, or Diabetes
por: Wang, Chi-Chuan, et al.
Publicado: (2013)

Repurposing of Drug Candidates for Treatment of Skin Cancer
por: Cortés, Hernán, et al.
Publicado: (2021)

Replication and fine-mapping of genetic predictors of lipid traits in African-Americans
por: Feng, QiPing, et al.
Publicado: (2017)

Validation of the diabetes, hypertension and hyperlipidemia (DHL) knowledge instrument in Malaysia
por: Lai, Pauline SM, et al.
Publicado: (2012)

The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis
por: Edwards, Brett D., et al.
Publicado: (2022)

Repurposing Auranofin as a Lead Candidate for Treatment of Lymphatic Filariasis and Onchocerciasis
por: Bulman, Christina A., et al.
Publicado: (2015)

Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
por: Santos, Joana M. O., et al.
Publicado: (2021)

A retrospective approach to evaluating potential adverse outcomes associated with delay of procedures for cardiovascular and cancer-related diagnoses in the context of COVID-19
por: Zheng, Neil S., et al.
Publicado: (2021)

Uncovering the relationship and mechanisms of Tartary buckwheat (Fagopyrum tataricum) and Type II diabetes, hypertension, and hyperlipidemia using a network pharmacology approach
por: Lu, Chao-Long, et al.
Publicado: (2017)

Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent
por: Tuan, Nguyen Minh, et al.
Publicado: (2019)

Systematically Prioritizing Candidates in Genome-Based Drug Repurposing
por: Challa, Anup P., et al.
Publicado: (2019)

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
por: Sakai, Norihiro, et al.
Publicado: (2023)

Elevated plasma migration inhibitory factor in hypertension–hyperlipidemia patients correlates with impaired endothelial function
por: Zhou, Boda, et al.
Publicado: (2016)

Repurposing of medications for pulmonary arterial hypertension
por: Toshner, Mark, et al.
Publicado: (2020)

Hyperlipidemia and Hypertension Are Associated With Intracerebral Hemorrhage Incidence: A Retrospective Study
por: Almuklass, Awad M, et al.
Publicado: (2023)

Evaluating phecodes, clinical classification software, and ICD-9-CM codes for phenome-wide association studies in the electronic health record
por: Wei, Wei-Qi, et al.
Publicado: (2017)

Monogenic hyperlipidemias
por: Krasi, Geraldo, et al.
Publicado: (2019)

Hyperlipidemias and Obesity
por: Thiriet, Marc
Publicado: (2019)

Therapy of Canine Hyperlipidemia with Bezafibrate
por: De Marco, V., et al.
Publicado: (2017)

Learning from Longitudinal Data in Electronic Health Record and Genetic Data to Improve Cardiovascular Event Prediction
por: Zhao, Juan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l9o4tm0fur3qdr3uqpln7o6vlg